Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

Fulvestrant 32Specimen Handling 29Letrozole 28Paclitaxel 23Carboplatin 19ribociclib 18pembrolizumab 18exemestane 18Capecitabine 17Trastuzumab 16palbociclib 15Tamoxifen 15Magnetic Resonance Spectroscopy 15Anastrozole 15Biopsy 13trastuzumab deruxtecan 12abemaciclib 12pertuzumab 11Radiotherapy 10Cyclophosphamide 9olaparib 7inavolisib 7elacestrant 7Standard of Care 7Radiation 7Mastectomy, Segmental 7Goserelin 7130-nm albumin-bound paclitaxel 7X-Rays 6Taxes 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Radiotherapy, Adjuvant × 30 days × Clear all
NCT06897488 2026-05-15

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

M.D. Anderson Cancer Center

Phase 2 Recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡